Ontology highlight
ABSTRACT: Background
An effective dengue vaccine should ideally induce broadly neutralizing antibody (nAb) responses against all 4 dengue virus (DENV) serotypes.Methods
We characterized the specificity and breadth of the nAb response to TAK-003, a live-attenuated tetravalent dengue vaccine, in serum samples from phase 2 and 3 clinical trials.Results
Microneutralization tests using postvaccination serum showed comparable neutralization against diverse DENV-1-4 genotypes. Reporter virus particle neutralization assays after depletion of anti-DENV-2 nAbs demonstrated that the nAb response to DENV-1, -3, and -4 comprises both type-specific (TS) and cross-reactive (CR) nAbs.Conclusions
Therefore, TAK-003 induces broad tetravalent TS and CR nAb responses.
SUBMITTER: DeMaso CR
PROVIDER: S-EPMC9704433 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature

DeMaso Christina R CR Karwal Lovkesh L Zahralban-Steele Melissa M Dominguez David D Springer Zhang-Li ZL Kaiser Maima M Palani Sunil S Rindfleisch Tim T Bohning Kelly K Hather Greg G Das Subash S Sharma Mayuri M Dean Hansi J HJ
The Journal of infectious diseases 20221101 11
<h4>Background</h4>An effective dengue vaccine should ideally induce broadly neutralizing antibody (nAb) responses against all 4 dengue virus (DENV) serotypes.<h4>Methods</h4>We characterized the specificity and breadth of the nAb response to TAK-003, a live-attenuated tetravalent dengue vaccine, in serum samples from phase 2 and 3 clinical trials.<h4>Results</h4>Microneutralization tests using postvaccination serum showed comparable neutralization against diverse DENV-1-4 genotypes. Reporter vi ...[more]